Indo Borax reports H1FY27 consolidated operating income up 16.0% to Rs 129.29 crore
Indo Borax & Chemicals · Chemicals & Petrochemicals
Key highlights
- H1FY27 consolidated Adjusted EBITDA rose 22.9% to Rs 28.09 crore, with an Adjusted EBITDA margin of 21.7%
- Company completed acquisition of 64.26% stake in Kronox Lab Sciences Ltd and appointed Mr. Suresh Kalra as MD and CEO at Kronox
- Board approved amalgamation of wholly owned subsidiary Indoborax Infrastructure Private Ltd with Indo Borax Chemicals, subject to regulatory approvals
Why it's rated major development: the year-on-year change is 71% (20% or more for adverse news)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Indo Borax & Chemicals
- Financial resultsMajor development· Adverse for the businessIndo Borax & Chemicals reports unaudited results for quarter and half year to 30 Sep 2026
- Acquisition / mergerMajor development· Adverse for the businessIndo Borax & Chemicals approves unaudited results for quarter and six months to September 30, 2026
- Acquisition / mergerNotableIndo Borax & Chemicals Ltd completes acquisition of 64.26% in Kronox Lab Sciences Ltd
Other acquisition / merger filings this fortnight
- Manoj Agrawal Acquires 1.00 Crore Shares in Cubical Financial Services Limited
- IndiGrid Infrastructure Trust Q2 FY27 Earnings Conference Call Transcript Released
- Cubical Financial Services Ltd announces promoter reclassification post open offer
- Novus Loyalty Limited approves acquisition of AutoPe Payment Solutions via share swap
- Shish Industries Limited files Composite Scheme of Amalgamation proposal
- Jubilant Ingrevia Limited updates on acquisition of 40% stake in Zettaone Technologies
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.